September 20, 2014 8:42 AM ET

Biotechnology

Company Overview of iPierian, Inc.

Company Overview

iPierian, Inc. offers industrialization of induced pluripotent stem cell technology; and discovery and development of therapeutics using cells as models of human disease. It develops therapies for neurodegenerative disease, focused on discovering monoclonal antibodies against targets of the Tau protein. It focuses on neurological diseases, including spinal muscular atrophy, amyotrophic lateral sclerosis, and Alzheimer’s disease. The company was formerly known as iZumi Bio, Inc. and changed its name to iPierian, Inc. in July, 2009. iPierian, Inc. was founded in 2007 and is based in South San Francisco, California. As of April 29, 2014, iPierian, Inc. operates as a subsidiary of Bristol-Myers ...

951 Gateway Boulevard

South San Francisco, CA 94080

United States

Founded in 2007

Phone:

650-872-4700

Fax:

650-872-4701

Key Executives for iPierian, Inc.

Chief Executive Officer and Director
Executive Chairman
Age: 55
Scientific Co-Founder and Co-Chair of The Scientific Advisory Board
Scientific Co-Founder and Co-Chair of The Scientific Advisory Board
Vice President of Corporate Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Angstrom Medica, Inc. United States
Leonard-Meron Biosciences, Inc. United States
Arcanum Discovery Inc. United States
Natural Industries, Inc. United States
Novagen, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 29, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact iPierian, Inc., please visit www.ipierian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.